JP Isham serves as the General Manager at Alchemist Investment Fund since November 2012, focusing on investments in sectors such as Food, Energy and Water Nexus, Biotechnology, Emerging Technology, and Material Science. In addition, JP has been a member of the Board of Advisors for American Gene Technologies International, Inc. since March 2013, specializing in bio-safe therapies for chronic diseases. As part of Gala’s Entertainment Advisory Board and Business Development team since June 2022, JP works in the realms of web3, blockchain, and entertainment portfolio management. Additional roles include Communications Consultant at Academy Enterprises, Executive Advisor at Sandstone Diagnostics, Daylight Digital, and Growth Cycle Africa, and contributions to Mobile Broadcast Company as Founder and Board member. JP holds a BA in Communications from California State University - East Bay.
This person is not in any teams
This person is not in any offices
American Gene Technologies International
1 followers
American Gene Technologies develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders.